View Post

COTA Signs Agreement with FDA for Breast Cancer Research

In Clinical Trials by Barbara Jacoby

By: Drew Boxler From: COTA Inc, a precision medicine technology company that uses real-world evidence (RWE) to bring clarity to cancer care, has signed an agreement with FDA’s science and technology incubator, Information Exchange and Data Transformation Program (INFORMED). The agreement will bring real-world evidence to the development of breast cancer treatments. Under the two-year research collaboration agreement, COTA …